Company Filing History:
1 out of 15 
1 out of 1 Years Active: 2019
Title: Thomas Hanke: Innovator in Pharmaceutical Chemistry
Introduction
Thomas Hanke is a notable inventor based in Hamburg, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds for medical applications. His work focuses on innovative solutions for treating neoplastic and infectious diseases.
Latest Patents
Hanke holds a patent for "Bicyclic tetrahydrothiazepine derivatives useful for the treatment of neoplastic and/or infectious diseases." This invention relates to bicyclic tetrahydrothiazepine of formula (I), wherein R to R, X, X, and R have the meanings as indicated in the description and claims. The invention further encompasses pharmaceutical compositions comprising such compounds, as well as their use as medicaments, especially in methods for the treatment or prevention of neoplastic and/or infectious diseases and in vitro methods. He has 1 patent to his name.
Career Highlights
Throughout his career, Thomas Hanke has worked with several prominent companies in the pharmaceutical industry. Notably, he has been associated with Apeiron Biologics AG and Evotec SE. His experience in these organizations has contributed to his expertise in drug development and innovation.
Collaborations
Hanke has collaborated with various professionals in his field, including Monika Ermann and Guenther Lametschwandtner. These collaborations have further enhanced his research and development efforts.
Conclusion
Thomas Hanke is a distinguished inventor whose work in pharmaceutical chemistry has the potential to impact the treatment of serious diseases. His innovative approaches and collaborations continue to drive advancements in the field.